Latest news with #GoldenTicketAward
Yahoo
02-05-2025
- Entertainment
- Yahoo
40 years in, Dollywood stands as tourism powerhouse
PIGEON FORGE, Tenn. (WJHL) — Dollywood is well into its 40th anniversary season, and on Friday, Dolly Parton will be in the park for a special celebration. News Channel 11 is participating in the celebration and exploring how the park attracts over 4 million visitors each year. News Channel 11's Anslee Daniel spoke with Leon Downey, Pigeon Forge's executive director of tourism, and Eugene Naughton, president of the Dollywood Company, to discuss how Silver Dollar City became Dollywood. 'The city saw the opportunity to partner with the Herschend family and with Dolly in 1986, and that was a major, first major attraction that the city had,' Downey said. 'And so it's grown every year since Dollywood became Dollywood.' Dollywood is the largest employer in Pigeon Forge and generates the highest tourism revenue in the area. TripAdvisor has awarded it the title of the number one theme park in the United States, and the park has also received the Golden Ticket Award for being the best theme park in the world. Downey stated that the park continues to thrive because 'the people just can't get enough of Dolly.' The Dreamer in Chief has plans to further enhance the park, including a new outdoor resort where guests can experience camping 'Dolly style.' Naughton stated that the ten-year master plan is a half-billion-dollar project that includes Dollywood's largest attraction yet: Take Flight. The upcoming attraction is set to open next season. 'Our largest attraction in our history that we've ever done,' he said. 'And I can promise it's nothing that the industry's ever seen and it'll carry Dolly's big dreams for sure.' Parton, a dedicated advocate for education, also prioritizes the educational needs of her employees. The Herschend Grow U program is a fully funded college tuition initiative available to all employees from their first day. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
01-05-2025
- Entertainment
- Yahoo
Waldameer's Ravine Flyer II ranks 4th among best coasters in US
(WJET/WFXP) – A beloved Erie roller coaster is receiving national recognition. Waldameer & Water World's Ravine Flyer II has been ranked the #4 roller coaster in the country, according to USA Today's 10BEST Readers' Choice Awards. Splash Lagoon offering free admission for firefighters on May 4 Thrill seekers and coaster fanatics were able to vote on coasters based on nominations from a panel of amusement park experts. According to voters, Ravine Flyer II's combination of modern and classic features contributed to its high placement on the list. Fans also enjoyed the coaster's fast-paced thrills and one-of-a-kind bridge. Poverty Knob hosts celebrity bartending night for Autism Society of NWPA Ravine Flyer II is no stranger to awards. The coaster won Amusement Today magazine's Golden Ticket Award for Best New Ride in a Park for 2008, the year of the coaster's inception. It is also consistently listed among their top wooden coasters. 'We are incredibly honored to have our premier coaster named one of the top roller coasters in the country,' said Steve Gorman, CEO of Waldameer. For more information about park hours, tickets, and attractions, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
13-03-2025
- Entertainment
- Yahoo
What to know for Silver Dollar City's 2025 opening
BRANSON, Mo. — Thursday marks the 65th year for Silver Dollar City as the park celebrates its season opening and Spring Break. Starting March 13, the park will be open for the spring season. Hours are 9:30 a.m. – 7:00 p.m. The 1880s-themed park is touting its new and improved Fire In The Hole ride, which won the 'Golden Ticket Award' for Best New Ride. Here is a list of festivals for SDC in 2025: Spring Break (March 13 – 31) Spring Exposition (April 10 – May 12) Bluegrass & BBQ (May 14 – 26) Summer Celebration (June 7 – August 3) Southern Gospel Picnic (August 21 – September 1) Harvest Festival (September 12 – October 26) An Old Time Christmas (November 1 – December 30) The park also announced a round of country music concerts in September including Montgomery Gentry ft. Eddie Montgomery, Sara Evans, and Lonestar. Here is a snapshot of ticket prices according to the park's website: 1-day tickets: Tickets start at $92 ages 12-64 Aged 4-11 and 65+ are $82 Ages 3 and under are free 2-day tickets: Tickets start at $112 ages 12-64 Ages 4-11 and 65+ are $102 Ages 3 and under are free 3-day tickets: Tickets start at $122 ages 12-64 Ages 4-11 and 65+ are $112 Ages 3 and under are free Season Passes (valid 3/13/25 – 1/4/26): Silver level: $159 plus tax Gold level: $219 plus tax Diamond level: $279 plus tax For a list of what perks each level gets and information on payment plans, click here. The water park portion is not open yet. According to park's website, the water park opens May 24th at 10:00 a.m. White Water opens that same day. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Associated Press
26-02-2025
- Business
- Associated Press
Argobio and the Institut Pasteur Launch Enodia Therapeutics: A Biotech Company With a New Approach for Targeted Protein Degradation
Argobio and the Institut Pasteur proudly announce the launch of Enodia Therapeutics, a groundbreaking French biotech company dedicated to block and degrade disease-causing proteins for treating cancer, inflammatory diseases and viral infections. 'With the convergence of an unprecedented diverse set of small molecules inhibitors of the Sec61/translocon molecular complex and advancements in generative artificial intelligence (AI), our vision is to develop novel small molecules drugs with good pharmaceuticals properties that could overcome the most critical limitations of today's medicines,' said Yves Ribeill, CEO of Enodia Therapeutics. This press release features multimedia. View the full release here: Enodia Therapeutics stems from pioneering research at the Institut Pasteur, with the discovery of the mechanism of action of Mycolactone, a natural Sec61 inhibitor responsible for Buruli Ulcers. 'Our infectious diseases research revealed a new way to target disease-causing proteins. This breakthrough highlights how fundamental research can help uncover entirely new therapeutic opportunities,' said Pr. Caroline Demangel, co-founder of Enodia Therapeutics and Head of the Immunobiology and Therapy Unit at the Institut Pasteur. Rooted in groundbreaking research at the Institut Pasteur and supported by Argobio, Enodia Therapeutics received Pfizer x BioLabs' prestigious Golden Ticket Award. 'This recognition supports our newest small molecule Targeted Protein Degrader (TPD) developed by the combined teams of Argobio and the Institut Pasteur. We are grateful for Pfizer's support and proud to be part of the vibrant BioLabs life sciences ecosystem in Paris Hotel Dieu, where collaboration and innovation are driving significant advancements in healthcare,' Yves Ribeill remarked. 'Pfizer is committed to supporting innovative biotech startups that have the potential to redefine patient care. We are excited to see how Enodia Therapeutics will harness its technology for novel treatment approaches,' said Dr. Luca Mollo, Vice-President and Medical Director at Pfizer in France. Enodia Therapeutics was incubated by Argobio, a premier French biotech studio company dedicated to fostering innovative science and accelerating its transition into a fully-fledged biotech company. The scientific project behind Enodia Therapeutics was supported by the Institut Pasteur's Innovation Accelerator. The aim of this program is to accelerate the market launch of innovative products resulting from laboratory discoveries. With the creation of its first spin-off company in 1997, the Institut Pasteur has been a pioneer in the creation of spin-off companies based on its research. To date the Institut Pasteur has been involved in the development of 38 spin-off companies. About Enodia Therapeutics Enodia Therapeutics, a French biotech company, is advancing first-in-class treatment for cancer, inflammatory diseases, and viral infections by targeting the translocon, a key gateway for protein secretion in the cell. Harnessing a cutting-edge AI-driven approach, we are developing selective small molecule inhibitors that block secretion and promote the degradation of pathological proteins at their source. Emerging from the Institut Pasteur and nurtured by Argobio, Enodia is built on breakthrough science with a singular mission: unveiling the translocon to unlock innovative therapies. For additional information visit: About Argobio Argobio is a French biotech start-up studio committed to transforming cutting-edge innovations into groundbreaking biotech companies. The studio sources early-stage therapeutic projects from leading European academic research institutions, focusing on rare diseases, neurological disorders, oncology, and immunology. By selecting and incubating these projects, Argobio aims to develop them into fully-fledged biotech companies, advancing them to significant Series A financing. With a team of highly experienced biotech entrepreneurs, the studio offers extensive expertise in novel drug discovery and development. For additional information visit About Institut Pasteur The Institut Pasteur, a non-profit foundation with recognized charitable status set up by Louis Pasteur in 1887, is today an internationally renowned center for biomedical research. In the pursuit of its mission to tackle diseases in France and throughout the world, the Institut Pasteur operates in four main areas: research, public health, training, and development of research applications. The Institut Pasteur is a globally recognized leader in infectious diseases, microbiology, and immunology, with research focusing on the biology of living systems. Among its areas of investigation are emerging infectious diseases, antimicrobial resistance, certain cancers, neurodegenerative diseases, and brain connectivity disorders. The Institut Pasteur's outstanding research is facilitated by the development of a technological environment of the highest standard, with core facilities for nanoimaging, computational biology and artificial intelligence. Since its inception, 10 Institut Pasteur scientists have been awarded the Nobel Prize for Medicine, including two in 2008 for the 1983 discovery of the human immunodeficiency virus (HIV) that causes AIDS. The Institut Pasteur is part of the Pasteur Network a worldwide network of more than 30 members on five continents, united by Pasteurian values, that contribute to global health. Since July 1, 2021, the Institut Pasteur is a research partner organization of Université Paris Cité. CONTACT: For media inquiries, please contact: Enodia Therapeutics - Argobio: Morgane Schwenzer [email protected] de presse de l'Institut Pasteur : Aurélie Perthuison Anne Burlet-Parendel SOURCE: Enodia Therapeutics Copyright Business Wire 2025. PUB: 02/26/2025 07:00 AM/DISC: 02/26/2025 07:03 AM
